Skip to main content

Table 2 The association between patient characteristics and tumor grade, tumor stage, muscle invasion, and recurrence after 18 month

From: Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer

Variable

Age (year)

Sex

Smoking

Family history of cancer

Mean (SD)

Male (%)

Female (%)

Yes (%)

No (%)

Positive (%)

Negative (%)

Tumor Grade

 Low grade

62.71 (10.45)

46 (54.10)

13 (61.90)

44 (54.3)

15 (60)

21 (44.70)

38 (64.40)

 High grade

63.32 (10.13)

39 (45.90)

8 (38.10)

37 (45.7)

10 (40)

26 (55.30)

21 (35.60)

P-Value

0.764 a

0.520 c

0.617 c

0.042 c

Tumor Stage

 Ta

62.02 (9.99)

40 (47.10)

10 (47.60)

38 (46.90)

12 (48.00)

17 (36.20)

33 (55.90)

 T1

67.92 (12.57)

10 (11.80)

3 (14.30)

10 (12.30)

3 (12.00)

5 (10.60)

8 (13.60)

 T2

65.15 (8.39)

26 (30.60)

7 (33.30)

24 (29.60)

9 (36.00)

21 (44.70)

12 (20.30)

 T3-T4

54.20 (9.00)

9 (10.60)

1 (4.80)

9 (11.10)

1 (4.00)

4 (8.50)

6 (10.20)

P-Value

0.005 b

0.865 c

0.734 c

0.060 c

Muscle Invasion

 Positive

62.60 (9.64)

35 (41.20)

8 (38.10)

33 (40.70)

10 (40)

25 (53.20)

18 (30.50)

 Negative

63.24 (10.73)

50 (58.80)

13 (61.90)

48 (59.30)

15 (60)

22 (46.80)

41 (69.50)

P-Value

0.757 a

0.797 c

0.947 c

0.018 c

Recurrence after 18 months

 Positive

60.92 (10.63)

49 (57.60)

12 (57.10)

49 (60.50)

12 (48.00)

36 (76.6)

25 (42.40)

 Negative

65.78 (9.13)

36 (42.40)

8 (42.90)

32 (39.50)

13 (52.00)

11 (23.4)

34 (57.60)

P-Value

0.015 a

0.976 c

0.296 c

< 0.001 c

  1. a Independent t test; b Analysis of variance (ANOVA); c Chi-square test